Análisis de sobrevida en pacientes con diagnóstico de Cáncer de Vulva en el Instituto Nacional del Cáncer.

Resumen

Introduction: In the World, Cancer of Vulva lies between 3 to 5% of all malignancies in the female reproductive tract; it is classified as a disease with a low frequency. Objective: To estimate the overall survival and conditional survival given one and two year’s survival after diagnostic in patients with vulvar cancer at the National Cancer Institute (INC). Material and Methods: Retrospective cohort study. We analyzed database, which includes patients diagnosed with vulvar cancer, between years 1997 to 2006. The selection was made over clinical registres and patient follow up on INC data base. Results: We analyzed 86 patients, mean age: 67.83 years (range 32-92) and median of 70 years. The 80.23% had squamous histology, 46.51% stage III, 48% received incomplete treatment, 39.5% consulted by the presence of vulvar mass and 17.65% had wound higher and lower lip. The overall survival at 5 years was 41.8%. There were statistically significant differences, depending on the stage of cancer (p = 0.02). The five year conditional survival given one and two year after diagnostic was 59% and 79% Conclusions: The overall survival of the first 5 years is 41.8% increasing to 59 and 79% in patients who had survived one and two year ofter dignostic. The stage of cancer and the initial time survival behaves as a prognostic factor in these patients.